Health Care: Drugs

Acorda Therapeutics Inc (ACOR: NASDAQ)

$31.63 0.31 | 0.99%
08/21/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 336.43M 305.81M 292.24M 191.01M
Cost of Sales 57.07M 48.53M 55.09M 27.00M
Gross Operating Profit 279.36M 257.28M 237.15M 164.01M
Selling, General, and Administrative Expenses 185.54M 168.69M 148.51M 133.32M
Research & Development 53.88M 53.88M 42.11M 30.60M
Operating Income before D & A (EBITDA) 39.94M 34.71M 46.53M 89.66K
Depreciation & Amortization 9.58M 9.11M 11.48M 8.52M
Interest Income 668.00K 552.00K 552.00K 574.84K
Other Income - Net 0.00 -6.00K -18.00K 8.26K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 31.03M 26.15M 35.59M -7.85M
Interest Expense 2.17M 1.88M 3.57M 3.92M
Pre-Tax Income 28.86M 24.27M 32.02M -11.77M
Income Taxes 12.42M -130.69M 1.41M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 16.44M 154.96M 30.60M -11.77M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 16.44M 154.96M 30.60M -11.77M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 16.44M 154.96M 30.60M -11.77M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
16.44M 154.96M 30.60M -11.77M
Preferred Dividends
Net Income Available To Common 16.44M 154.96M 30.60M -11.77M
Basic EPS from Continuing Ops. 0.41 3.93 0.78 -0.31
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.41 3.93 0.78 -0.31
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.41 3.93 0.78 -0.31
Basic Normalized Net Income/Share 0.41 3.93 0.78 -0.31
EPS fr Continuing Ops. 0.39 3.84 0.76 -0.31
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.39 3.84 0.76 -0.31
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.39 3.84 0.76 -0.31
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.39 3.84 0.76 -0.31
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACOR

Latest ACOR Headlines from TheStreet

More Financial News for ACOR

Press Releases for ACOR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter